IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $335,094 | -52.5% | 21,605 | -45.6% | 0.01% | -57.1% |
| Q4 2022 | $704,853 | +79.8% | 39,710 | -43.4% | 0.01% | +75.0% |
| Q3 2022 | $392,000 | +43.1% | 70,138 | +0.1% | 0.01% | +60.0% |
| Q2 2022 | $274,000 | -29.0% | 70,064 | +0.0% | 0.01% | -16.7% |
| Q1 2022 | $386,000 | -26.8% | 70,051 | +13.3% | 0.01% | -14.3% |
| Q4 2021 | $527,000 | +2.7% | 61,851 | +4.9% | 0.01% | 0.0% |
| Q3 2021 | $513,000 | +147.8% | 58,951 | +202.0% | 0.01% | +250.0% |
| Q2 2021 | $207,000 | – | 19,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |